These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21704829

  • 1. Is survivin the potential Achilles' heel of cancer?
    Lladser A, Sanhueza C, Kiessling R, Quest AF.
    Adv Cancer Res; 2011; 111():1-37. PubMed ID: 21704829
    [Abstract] [Full Text] [Related]

  • 2. Survivin: an inhibitor of apoptosis in pediatric cancer.
    Fangusaro JR, Caldas H, Jiang Y, Altura RA.
    Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
    [Abstract] [Full Text] [Related]

  • 3. Survivin in skin pathologies.
    Bongiovanni L, Müller EJ, Della Salda L.
    Exp Dermatol; 2011 Jun; 20(6):457-63. PubMed ID: 21585553
    [Abstract] [Full Text] [Related]

  • 4. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
    Kim YS, Jin HO, Seo SK, Woo SH, Choe TB, An S, Hong SI, Lee SJ, Lee KH, Park IC.
    Biochem Pharmacol; 2011 Aug 01; 82(3):216-26. PubMed ID: 21601561
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Edenfield HR, Glickman JN, Yeap BY, Sugarbaker DJ, Bueno R.
    J Pathol; 2007 Mar 01; 211(4):447-54. PubMed ID: 17253596
    [Abstract] [Full Text] [Related]

  • 6. Targeting survivin in cancer: the cell-signalling perspective.
    Kanwar JR, Kamalapuram SK, Kanwar RK.
    Drug Discov Today; 2011 Jun 01; 16(11-12):485-94. PubMed ID: 21511051
    [Abstract] [Full Text] [Related]

  • 7. Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.
    Zhang Z, Liao H, Chen X, Zheng Y, Liu Y, Tao X, Gu C, Dong L, Duan T, Yang Y, Liu X, Yu Y, Feng Y.
    Eur J Obstet Gynecol Reprod Biol; 2011 Mar 01; 155(1):69-74. PubMed ID: 21074309
    [Abstract] [Full Text] [Related]

  • 8. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.
    Chiou SK, Jones MK, Tarnawski AS.
    Med Sci Monit; 2003 Apr 01; 9(4):PI25-9. PubMed ID: 12709681
    [Abstract] [Full Text] [Related]

  • 9. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M, Cantú D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J.
    BMC Cancer; 2006 Feb 27; 6():45. PubMed ID: 16504151
    [Abstract] [Full Text] [Related]

  • 10. Survivin isoform Delta Ex3 regulates tumor spheroid formation.
    Espinosa M, Ceballos-Cancino G, Callaghan R, Maldonado V, Patiño N, Ruíz V, Meléndez-Zajgla J.
    Cancer Lett; 2012 May 01; 318(1):61-7. PubMed ID: 22155745
    [Abstract] [Full Text] [Related]

  • 11. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y, Zeng H, Wang X, Huang Y, Chen N, Ge B, Tang L, Luo Q.
    Exp Eye Res; 2009 Jan 01; 88(1):4-11. PubMed ID: 18955046
    [Abstract] [Full Text] [Related]

  • 12. The role of survivin as a new target of diagnosis and treatment in human cancer.
    Yamamoto T, Tanigawa N.
    Med Electron Microsc; 2001 Dec 01; 34(4):207-12. PubMed ID: 11956993
    [Abstract] [Full Text] [Related]

  • 13. Survivin, versatile modulation of cell division and apoptosis in cancer.
    Altieri DC.
    Oncogene; 2003 Nov 24; 22(53):8581-9. PubMed ID: 14634620
    [Abstract] [Full Text] [Related]

  • 14. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G, Rödel C, Stauber RH, Knauer SK, Bache M, Kappler M, Rödel F.
    Strahlenther Onkol; 2007 Nov 24; 183(11):593-9. PubMed ID: 17960333
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 24; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

  • 16. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H, Sen S, Mathur M, Bahadur S, Singh N.
    Head Neck; 2004 Aug 24; 26(8):733-40. PubMed ID: 15287041
    [Abstract] [Full Text] [Related]

  • 17. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
    Xue Z, Sun PH, Zhu LM, Jiang SH, Qiao MM, Chi AL, Tu SP.
    Oncol Rep; 2011 Apr 24; 25(4):1039-46. PubMed ID: 21279308
    [Abstract] [Full Text] [Related]

  • 18. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
    Kleinberg L, Flørenes VA, Nesland JM, Davidson B.
    Am J Clin Pathol; 2007 Sep 24; 128(3):389-97. PubMed ID: 17709312
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical detection of survivin in canine lymphoma.
    Wimmershoff J, Polkinghorne A, Grest P, Schade B, Marchal T, Keller SM, Guscetti F.
    J Comp Pathol; 2010 May 24; 142(4):311-22. PubMed ID: 20116802
    [Abstract] [Full Text] [Related]

  • 20. Coexpression of survivin and PCNA in pituitary tumors and normal pituitary.
    Wasko R, Waligorska-Stachura J, Jankowska A, Warchol JB, Liebert W, Sowinski J.
    Neuro Endocrinol Lett; 2009 May 24; 30(4):477-81. PubMed ID: 20010504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.